Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, PPIs, and Diet in LPRD
NCT07611162Phase 4Not yet recruiting
- Sponsor
- University of Mons
- Start
- May 2026
- Primary completion
- May 2030
- Countries
- 1
01
Overview
A Phase 4 trial of alginic acid, magaldrate, sucralfate in Laryngopharyngeal reflux disease (LPR), sponsored by University of Mons. Planned start May 2026; status: not yet recruiting.
02
Drugs
alginic acidmagaldratesucralfate
03
Conditions
Laryngopharyngeal reflux disease (LPR)
Beyond the preview
Go deeper on NCT07611162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07611162.